• GlaxoSmithKline (GSK) Drug Fails to Hit Goal in Breast Cancer Trial More...

• Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data atCTRC-American Association for Cancer Research San Antonio Breast Cancer Symposium More...

• AEterna Zentaris (AEZS) Presents Positive Preclinical Data in Breast Cancer on AEZS-131, a Highly Selective Erk 1/2 Inhibitor, at San Antonio Breast Cancer Symposium More...

• Gilead Sciences Ltd. (GILD) Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir, an Integrase Inhibitor for HIV More...

• Stress Early in Pregnancy Linked to Fewer Baby Boys, New York University Study More...

• Starchy Foods May Boost Risk of Breast Cancer Recurrence, University of California, San Diego (UCSD) Study More...

• Taxi Driver Training Changes Brain Structure, University College London Study More...

• Early Ovary Removal May Raise Arthritis, Osteoporosis Risk, Johns Hopkins University Study More...

• Arthritis Major Contributor to Physical Inactivity, Arthritis Foundation Study More...

• Omni Bio Pharmaceutical Patent Issued for Treatment of Diabetes More...

• Fate Therapeutics Secures Foundational Patent for iPS Cell Reprogramming More...

• Bayer HealthCare Pharmaceuticals (BAYA.F) Release: FDA Panel Calls for Label Updates for Drospirenone-Containing Oral Contraceptives More...

• Pharmacyclics, Inc. (PCYC) Could Score $975 Million in Johnson & Johnson (JNJ) Pact More...

• Johnson & Johnson (JNJ)'s Janssen Biotech Inc. and Molecular Partners AG Expand Agreement to Immunological Diseases in Deal Worth $800 Million More...

• Ezose Sciences, Inc. in New Agreement with Merck & Co., Inc. (MRK) to Advance Glycan Biomarker Discovery in Diabetes More...

• Moberg Derma and Menarini Group Sign Agreement for Emtrix in Italy More...

• $60 Million Later, Biotech Altea Therapeutics Calls it Quits More...

• CeNeRx BioPharma, Inc. Completes $4.85 Million Financing More...

• Oxygen Biotherapeutics, Inc. (OXBO) Announces Registered Financing for up to $7.5 Million in Gross Proceeds More...

• TaiGen Biotechnology Obtains the Worldwide Rights for Nemonoxacin More...

• U.S. Federal Trade Commission Approves Laboratory Corporation of America Holdings (LabCorp) (LH)'s Acquisition of Orchid Cellmark (ORCH) More...

• SDIX (SDIX) Completes Sale of Water Quality Assets to Modern Water plcfor $4.5 Million More...

• AVI BioPharma, Inc. (AVII) Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations More...

• Sucampo Pharmaceuticals, Inc. Promotes Birgit Roerig, Ph.D. to Vice President, Pharmacology and Toxicology More...

• BioSpecifics Technologies Corporation (BSTC) Announces Appointment of George Gould to Board of Directors More...

• Gentium S.p.A. Announces Changes to Board of Directors More...

• PURE Bioscience (PURE) to Report First Quarter Fiscal 2012 Results on December 15 More...

• Pall Corporation (PLL) First Quarter Sales and Orders Increase Over 16% More...